Literature DB >> 27600165

Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products.

Mark W Skinner1, P Ann Hedlund Hoppe2, Henry G Grabowski3, Richard Manning4, Raffi Tachdjian5, James F Crone6, Stuart J Youngner7.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27600165     DOI: 10.1111/trf.13764

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  2 in total

1.  Evaluation of EU legislation on blood: a bioethical point of view.

Authors:  Carlo Petrini
Journal:  J Blood Med       Date:  2017-11-09

2.  Transfusion medicine: Overtime paradigm changes and emerging paradoxes.

Authors:  O Garraud; T Vuk; M Lozano; J-D Tissot
Journal:  Transfus Clin Biol       Date:  2020-10-06       Impact factor: 1.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.